Patents for A61K 103 - Radioactive metals (481) |
---|
08/22/2007 | CN101020067A Transdermal plaster prepn for 99m TC methylene diphosphonate |
08/16/2007 | WO2007009191A8 Method for treating cancer |
08/08/2007 | CN1330635C Radioactive rhenium-N-accessory ingredient of alkyl dinitrogen disulfide for curing liver cancer and preparation method |
08/02/2007 | US20070178045 Cyclopeptide derivatives with anti-integrin activity |
08/01/2007 | EP1812115A2 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy |
08/01/2007 | CN101007850A Engomphosis and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen |
08/01/2007 | CN101007176A Drug for treating rheumatoid, rheumatic and other bone and joint diseases |
07/04/2007 | EP1620134B1 Microwave method for preparing radiolabelled gallium complexes |
06/27/2007 | CN1985997A Degradable radioactive sponge and its making process |
06/20/2007 | EP1796738A2 Diagnostic compounds for targeting a chemokine receptor |
06/20/2007 | EP1796737A2 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, as well as methods of use thereof |
05/10/2007 | WO2007052267A2 Biodegradable composite for internal local radiotherapy |
05/09/2007 | CN1314456C Medicament box of 2beta-[N,N'-di(2-mercaptoethyl) ethylene diamine] methyl-3 beta-(4- chlorphenyl) tropane |
04/25/2007 | CN1953772A Contrast medium for receptor of angiotensin ii |
04/04/2007 | EP1768708A2 N4 chelator conjugates |
04/04/2007 | CN1308339C 99m Tc marked polyamine complex as tumor diagnosing developing agent and its preparation |
02/28/2007 | EP1381397B1 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
02/14/2007 | CN1912111A Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |
01/25/2007 | WO2007009191A1 Method for treating cancer |
01/24/2007 | EP1390405B1 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
11/15/2006 | CN1861616A Compound for tumour display and caring and preparation process thereof |
11/09/2006 | WO2006116798A1 A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate |
11/08/2006 | CN1283647C Technetium-99m marked isonitrile group mating material, preparing process and uses thereof |
09/21/2006 | WO2006072336A3 Radioactive metal complexes based on bispidine and derivatives thereof |
09/13/2006 | EP1699494A2 Contrast agent imaging angiotensin ii receptors |
08/23/2006 | CN1270774C Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
08/16/2006 | EP1690552A2 Radiopharmaceutical kits stabilised by means of cyclodextrins |
08/09/2006 | CN1268629C Isonitrile compound for radioactive Tc-99m label and its preparing and application |
08/02/2006 | EP1684809A1 Chelate based scaffolds in tumor targeting |
08/02/2006 | EP0730472B1 Immobilized labelling method |
07/27/2006 | WO2006008496A3 Improved n4 chelator conjugates |
07/13/2006 | WO2006072336A2 Radioactive metal complexes based on bispidine and derivatives thereof |
06/22/2006 | WO2006064227A1 Magnetic resonance contrast media |
06/22/2006 | WO2006064175A1 STABILISED 99mTC COMPOSITIONS |
06/14/2006 | CN1786009A Application of 99TcmN (CPEDTC)2 compounding agent in tumour imaging field |
06/07/2006 | EP1663318A1 A radioisotope-chitosan complex for treatment of prostate cancer |
05/03/2006 | CN1254276C Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
04/26/2006 | CN1762499A Medicament box of 2beta-[N,N'-di(2-mercaptoethyl) ethylene diamine] methyl-3 beta-(4- chlorphenyl) tropane |
04/19/2006 | CN1251767C Kit for radiolabeling proteins with yttrium-90 |
03/22/2006 | EP1635880A2 Microparticles for microarterial imaging and radiotherapy |
02/01/2006 | EP1620134A1 Microwave method for preparing radiolabelled gallium complexes |
01/26/2006 | WO2006008496A2 Improved n4 chelator conjugates |
01/18/2006 | EP1615671A1 Microspheres comprising therapeutic and diagnostic radioactive isotopes |
01/21/2004 | EP1381397A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
09/17/2003 | EP1091763B1 Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters |
05/07/2003 | EP1307239A1 Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex |
03/19/2003 | EP1292338A2 Stabiliser for radiopharmaceuticals |
03/12/2003 | EP1289570A1 Liposomal encapsulation of chelated actinium-225 and uses thereof |
12/31/2002 | CA2044812C Radiopharmaceutical formulations, their method of administration and process of preparation |
12/18/2002 | EP1265641A2 Imaging agents for diagnosis of parkinson's disease |
04/10/2002 | EP1195168A2 Ternary radiopharmaceutical complexes |
04/18/2001 | EP1091763A2 Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters |
04/18/2001 | EP1091757A2 Alpha emitting constructs and uses thereof |
11/02/2000 | EP1047457A2 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE |
10/18/2000 | CN1057470C Ether isonitriles and radiolabeled complexes thereof |
06/02/2000 | WO1999061097A9 Alpha emitting constructs and uses thereof |
02/17/2000 | WO2000000223A3 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS |
02/10/2000 | WO1999036105A3 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE |
02/03/2000 | WO1999061097A3 Alpha emitting constructs and uses thereof |
02/02/2000 | EP0975374A1 Radiometal-binding peptide analogues |
01/06/2000 | WO2000000223A2 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS |
12/02/1999 | WO1999061097A2 Alpha emitting constructs and uses thereof |
10/21/1999 | WO1999036105A9 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE |
07/22/1999 | WO1999036105A2 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE |
07/22/1999 | CA2318231A1 Use of radiolabeled monoclonal igm in therapy for cancer and autoimmune disease |
09/09/1998 | EP0862464A1 Amino acid analogs for tumor imaging |
06/09/1998 | US5762907 Frozen radiopharmaceutical formulations |
10/30/1996 | CN1033143C Radiopharmaceutical formulations, their method of administration and process of preparation |
08/20/1992 | WO1992013563A1 Antitumoral preparation and method of making same |
08/19/1992 | CN1063615A Radiopharmaceutical formulations, their method of administration and process of preparation |
07/14/1992 | CA1305160C Ether isonitriles and radiolabeled complexes thereof |
05/20/1992 | EP0216864B1 Detection of activated platelets with antibodies to cell surface antigens |
01/08/1992 | CN1057585A Ether isonitriles and radiolabeled complexes thereof |
12/27/1991 | EP0462787A1 Radiopharmaceutical formulations, their method of administration and process of preparation |
01/29/1991 | US4988827 Ether isonitriles and radiolabeled complexes thereof |
12/27/1989 | CA1264029A1 Detection of activated platelets with antibodies to cell surface antigens |
09/26/1989 | EP0216864A4 Detection of activated platelets with antibodies to cell surface antigens. |
04/11/1989 | US4820505 Detection of activated platelets with antibodies to thrombospondin |
08/26/1987 | EP0233368A1 Ether isonitriles and radiolabeled complexes thereof |
04/08/1987 | EP0216864A1 Detection of activated platelets with antibodies to cell surface antigens. |
10/09/1986 | WO1986005693A1 Detection of activated platelets with antibodies to cell surface antigens |